vendredi 7 avril 2017
GSK recalls nearly 600,000 asthma inhalers in U.S.
GSK Plc is voluntarily recalling more than 593,000 Ventolin asthma inhalers from U.S. hospitals, pharmacies, retailers and wholesalers due to a defect that may cause them to deliver fewer doses of the medicine than indicated.
Related Posts:
Cases of HPV-related oral cancers have risen significantly in Canada, study finds- Ontario mom mourning her daughter shocked to find she could overrule her wish to donate organs
- Citing overdose 'crisis,' police to allow unsanctioned Toronto injection site
- Childhood malnutrition in residential schools linked to diabetes, heart disease in adults
- Why Ontario's Catholic hospitals may no longer be able to pass on offering assisted death
Articles
0 comments:
Enregistrer un commentaire